Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-19-053066

Options or other derivatives

  • Director acquired 22,222 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SATO VICKI L Director 2019-10-10 Grant or award · Stock Option (Right to Buy) +22,222 22,222 D: show line 1 in the form
Loading xslF345X03/doc4.xml…